TRex Bio Inc. (TRXB) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

TRex Bio Inc. (TRXB) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $112.5M, listed on NASDAQ, employing roughly 60 people, carrying a beta of 0.00 to the broader market. Trex Bio, Inc. Led by Marion Johnston Erwin, public since 2026-10-09.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for TRXB as of 2026-10-16; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →